NUREXONE BIOLOGIC INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.51 CAD | -1.92% |
|
-13.56% | +72.88% |
| Apr. 25 | NurExone Biologic Announces OTCQB Listing And DTC Eligibility | MT |
| Apr. 02 | NurExone Biologic Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Evolution of the average Target Price on NurExone Biologic Inc.
Price target over the last 5 years
History of analyst recommendation changes
b7fcaa76c5bdd6f1c430a5b.loprQeZG9fpONMxjyI5GX_n66YpgOc7bI8F86Tzy1EI.3O1fO7Y_r8oRVoAgjOs0EY2tnOABXJy3SYAstlrFjSHn4SoVoweMinYHgQ~9160ae81fee47e8782f7a0e1392edb79
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.3749
USD
Average target price
2.907
USD
Spread / Average Target
+675.39%
High Price Target
2.907
USD
Spread / Highest target
+675.39%
Low Price Target
2.907
USD
Spread / Lowest Target
+675.39%
Consensus detail
Consensus revision (last 18 months)
EPS Revisions
- Stock Market
- Equities
- NRX Stock
- Consensus NurExone Biologic Inc.
